 | A comprehensive genomics facility for the UQ Diamantina Institute for Cancer, Immunology and Metabolic Medicine, 2008 - 2015
Funded by: Australian Cancer Research Foundation, PA Foundation |
| First aid for burns: the use of ice water and ice?, 2007 - 2010
Funded by: National Health and Medical Research Council |
| Identification of clinically significant subtypes of head and neck cancer cells, 2007 - 2009
Funded by: National Health and Medical Research Council |
| The molecular basis for the initiation of squamous differentiation, 2006 - 2007
Funded by: Queensland Cancer Fund |
| Predicting clinical response of osteogenic sarcoma to chemotherapy using gene expression profiling, 2004 - 2005
Funded by: Wesley Research Institute Limited |
| PAH Cancer Collaborative Group: QCF Collaborative Research Grant funds, 2004 - 2008
Funded by: Princess Alexandra Hospital Auxiliary |
| Developing E2F inhibitors as a potential therapeutic strategy for the treatment of head and neck squamous cell carcinoma, 2004 - 2009
Funded by: Garnett Passe/Rodney Williams Memorial Foundation |
| Development Of A Novel Therapy For The Treatment Of Epidermal Squamous Cell Carcinoma, 2004 - 2006
Funded by: National Health and Medical Research Council |
| Treatment Of Virally-Induced Cancers By RNA Interference, 2004 - 2006
Funded by: National Health and Medical Research Council |
| PAHF block funding, 2003 - 2004
Funded by: Princess Alexandra Hospital Auxiliary |
| E2F inhibitors as anticancer agents for squamous cell carcinoma., 2002 - 2002
Funded by: Princess Alexandra Hospital Auxiliary |
| Characterisation of a TGFb1-independent but SMAD7-dependent pathway regulating squamous differentiation, 2001 - 2004
Funded by: Association for International Cancer Research |
| Development of a differentiation therapy for head and neck cancer, 2001 - 2003
Funded by: Garnett Passe/Rodney Williams Memorial Foundation |
| E2F Inhibitors As Anticancer Agents For Squamous Cell Carcinoma, 2001 - 2001
Funded by: Princess Alexandra Hospital Auxiliary |
| E2F Inhibitors as Anticancer Agents for Squamous Cell Carcinoma, 2001 - 2003
Funded by: National Health and Medical Research Council |
| Potential use of novel growth inhibitors for the treatment of head and neck cancers., 2001 - 2001
Funded by: University of Queensland |
| A) Biological characterisation of neoplastic progression in keratinocytes B) E2F inhibitors as anti skin cancer agents, 2000 - 2000
Funded by: Princess Alexandra Hospital Auxiliary |
| Biological characterisation of neoplastic progression in keratinocytes, 2000 - 2001
Funded by: Queensland Cancer Fund |
| Development of new therapies for skin cancer, 1999 - 1999
Funded by: Government Employees Medical Research Fund |
| E2F as a target for anticancer therapy of skin tumours, 1999 - 1999
Funded by: Cancer Bequest Fund |
| Identifying novel therapeutic targets for skin cancer therapy, 1999 - 2003
Funded by: Queensland And Northern New South Wales Lions Medical Research Foundation |
| The Role of E2F1 in Skin Cancer Development, 1999 - 1999
Funded by: Princess Alexandra Hospital Auxiliary |
| Molecular Mechanisms Regulating Growth Arrest During Epithelial Differentiation, 1998 - 1999
Funded by: Princess Alexandra Hospital Auxiliary |
| Targetted inhibition of E2F activity as a potential therapy for head and neck cancers, 1998 - 1998
Funded by: Garnett Passe/Rodney Williams Memorial Foundation |
| The role of E2F in skin cancer development, 1998 - 1998
Funded by: Queensland Cancer Fund |
| Page: | 1 2  |
| |
| Select all records |
| |
» Research Groups
